Medicare GLP-1 Bridge: $50 Copay Starts July 1, 2026 — But Only Through 2027
CMS, under Dr. Mehmet Oz, launches the Medicare GLP-1 Bridge on July 1, 2026, capping out-of-pocket costs at $50/month for select GLP-1 drugs for Part D enrollees with obesity, but the temporary program ends December 31, 2027 and does not count toward Part D deductibles or out-of-pocket limits.
On July 1, 2026, the Centers for Medicare & Medicaid Services — under the Trump administration's Dr. Mehmet Oz — launched the Medicare GLP-1 Bridge, a temporary program that caps monthly out-of-pocket costs at $50 for certain GLP-1 weight-loss drugs (like Wegovy) for eligible Part D enrollees with obesity. The agency frames this as a cost-cutting win for seniors. But the program ends December 31, 2027, does not count toward Part D deductibles or out-of-pocket maximums, and covers only a select list of drugs. Patients could face a coverage cliff just as they stabilize on medication, while drugmakers avoid any long-term price controls. Absent permanent coverage or price negotiation, this is a limited political gesture — not structural reform.
The humanitarian alternative
Congress should pass the Treat and Reduce Obesity Act (TROA), which would make coverage of anti-obesity medications permanent under Medicare Part D. Simultaneously, CMS should use its existing authority under the Inflation Reduction Act to negotiate prices for GLP-1 drugs, ensuring sustained affordability without sunset dates. A permanent program with negotiated prices would lower federal spending by an estimated $85 billion over a decade while giving millions of patients continuity of care.
Falsifiable predictions
What this entry claims will happen, and what data would prove it wrong. The Reckoner revisits these against current reality.
- The Medicare GLP-1 Bridge will expire on December 31, 2027 without permanent coverage unless Congress acts.
- More than 500,000 Medicare Part D enrollees will use the $50 copay program in its first year.
Original source — excerpted
news Big Medicare change slashes weight-loss drug costs for eligible seniors"NEW You can now listen to Fox News articles! Millions of Medicare beneficiaries struggling with obesity could soon see the cost of weight-loss drugs plummet, a..."